| Josie Trovato, RN | |
|
500 N Bridge St, Bridgewater, NJ 08807-2135 | |
| (908) 785-2800 | |
| (908) 704-1790 |
| Full Name | Josie Trovato |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 500 N Bridge St, Bridgewater, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336704659 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NR12087800 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Josie Trovato, RN 500 N Bridge St, Bridgewater, NJ 08807-2135 Ph: (908) 785-2800 | Josie Trovato, RN 500 N Bridge St, Bridgewater, NJ 08807-2135 Ph: (908) 785-2800 |
News Archive
Abbott announced today that it has introduced the PLEX-ID Biothreat Assay, which is designed to detect and distinguish 17 different biothreat pathogens.
Although stem cells hold incredible promise in the fight against certain diseases, in cancer they're anything but helpful. In fact, mounting evidence is showing that a tumor's growth and spread may depend on "cancer stem cells," which comprise only a very small subset of the tumor.
Northwestern Medicine researchers at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University have found that a new, nontoxic drug made from a chemical in soy could prevent the movement of cancer cells from the prostate to the rest of the body.
Two recent FDA approvals have prompted the National Comprehensive Cancer Network (NCCN) to update the NCCN Clinical Practice Guidelines in Oncology(TM) for Non-Hodgkin's Lymphomas to include ofatumumab (Azerra(TM), GlaxoSmithKline) and romidepsin (Istodax(R), Gloucester Pharmaceuticals) as treatment options for select patients with two types of Non-Hodgkin's Lymphomas.
Researchers at Mount Sinai School of Medicine, the University of Manchester, and the MD Anderson Cancer Center have found a new role for an oncogenic signaling pathway in embryonic stem cell (ESC) self-renewal and in reprogramming adult cells into an ESC-state, which will aid in the development of future cancer therapies.
› Verified 8 days ago
Nancy Fender, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 N Bridge St, Bridgewater, NJ 08807 Phone: 908-725-2800 Fax: 908-704-1790 | |
Ruta Bernadette Grumulaitis, RN, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 N Bridge St, Bridgewater, NJ 08807 Phone: 908-725-2800 Fax: 908-704-1790 | |
Temilade Adesanya, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1065 Us Highway 22, Bridgewater, NJ 08807 Phone: 844-722-1580 | |
Mrs. Jacinta P San Luis, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 N Bridge St, Bridgewater, NJ 08807 Phone: 908-725-2800 Fax: 908-704-1790 | |
Susan P. Williams, RN, APN, C. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 540 Route 22, Bridgewater, NJ 08807 Phone: 908-722-1881 | |
Tonya Mcgahey, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 N Bridge St, Bridgewater, NJ 08807 Phone: 908-725-2800 Fax: 908-704-1790 |